Corrigendum to “Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals” [J. JCTE 2 (2015) 55–60, (S2214623715000496), (10.1016/j.jcte.2015.02.003)];Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals

Journal of Clinical and Translational Endocrinology

Volumn 2, Issue 2, 2015, Pages 55-60

  Weinand, Jamie D ^a   Safer, Joshua D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hormone therapy; Review; Safety; Transgender; Transsexual

Indexed keywords

CHOLESTEROL; CREATININE; ESTROGEN; GLUCOSE; HEMOGLOBIN; HORMONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANDROGEN DEPRIVATION THERAPY; AUTOIMMUNE DISEASE; BODY MASS; BONE MASS; CANCER INCIDENCE; CANCER MORTALITY; CARDIOVASCULAR RISK; CASE STUDY; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL SUPERVISION; CREATININE BLOOD LEVEL; DRUG SAFETY; ESTROGEN THERAPY; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEALTH CARE PERSONNEL; HEART INFARCTION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYPERCOAGULABILITY; HYPOPHYSIS; INSULIN SENSITIVITY; LIVER FUNCTION TEST; MALE TO FEMALE TRANSGENDER; METABOLIC DISORDER; NEOPLASM; ONCOLOGY; OSTEOPENIA; PREVALENCE; PROLACTINOMA; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TRANSGENDER; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID URINE LEVEL; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84925127060     PISSN: None     EISSN: 22146237     Source Type: Journal    
DOI: 10.1016/j.jcte.2024.100334     Document Type: Erratum

References (72)

1. I. Gardner, and J. Safer Progress on the road to better medical care for transgender patients Curr Opin Endocrinol Diabetes Obes 20 6 2013 55308
2. Joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 June 24, 2014 https://endo.confex.com/endo/2014endo/webprogram/Paper14354.html
3. H. Asscheman, G. Tsjoen, A. Lemaire, M. Mas, M. Meriggiola, and A. Mueller 2013 venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review Andrologia 46 7 2013 Aug 15
4. L. Gooren, E. Giltay, and M. Bunck Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience J Clin Endocrinol Metab 93 1 2008 19 25
5. K. Wierckx, E. Elaut, E. Declercq, G. Heylens, G. De Cuypere, and Y. Taes Prevalence of cardiovascular disease and cancer during cross-sex HRT in a large cohort of trans persons: a case-control study Eur J Endocrinol 169 4 2013 471 478
6. K. Wierckx, S. Mueller, S. Weyers, E. Van Caenegem, G. Roef, and G. Heylens Long-term evaluation of cross-sex hormone treatment in transsexual persons J Sex Med 9 10 2012 2641 2651
7. K. Lehrman Pulmonary embolism in a transsexual man taking diethylstilbestrol JAMA 235 2 1976
8. M. deMarinis, and E. Arnett Cerebrovascular occlusion in a transsexual man taking mestranol Arch Intern Med 138 11 1978 1732 1733
9. G. Sare, L. Gray, and P. Bath Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis Eur Heart J 29 2008 2031 2041
10. P. Valenzuela, and J. Simon Nanoparticle delivery for transdermal HRT Nanomedicine Suppl. 1 2012 S83 S89
11. M. Goodman Are all estrogens created equal? A review of oral vs. transdermal therapy J Womens Health 21 2 2012 161 169
12. C. Bagot, M. Marsh, M. Whitehead, R. Sherwood, L. Roberts, and R. Patel The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy J Thromb Haemost 8 8 2010 1736 1744
13. J. Ott, U. Kaufmann, E. Bentz, J. Huber, and C. Tempfer Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex HRT Fertil Steril 93 4 2010 1267 1272
14. R. Wilson, A. Spiers, J. Ewan, P. Johnson, C. Jenkins, and S. Carr Effects of high dose oestrogen therapy on circulating inflammatory markers Maturitas 62 3 2009 281 286
15. C. Fortin, T. Klein, H. Messmore, and J. O'Connel Myocardial infarction and severe thromboembolic complications. As seen in an estrogen-dependent transsexual Arch Intern Med 144 5 1984 1082 1083
16. P. Lunetta, and A. Penttilä Sudden death by arrhythmogenic right ventricular dysplasia in a South American transsexual? Med Sci Law 38 3 1998 265 271
17. G. Mullins, S. O'Sullivan, J. Kinsella, D. McEnroy, D. Crimmins, and S. Whyte Venous and arterial thrombo-embolic complications of hormonal treatment in a male-to-female transgender patient J Clin Neurosci 15 6 2008 714 716
18. C. Lee, and S. Basaria Syncope in a transsexual male J Androl 27 2 2006 164
19. A. Mowl, J. Grogg, and J. Klein Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy Clin Exp Optom 92 5 2009 449 453
20. S. Park, C. Cheng, L. Lim, and D. Gerber Secondary intracranial hypertension from testosterone therapy in a transgender patient Semin Opthalmol 29 3 2013 [Epub ahead of print]
21. H. Inoue, N. Nishida, N. Ikeda, A. Tsuji, K. Kudo, and M. Hanagama The sudden and unexpected death of a female-to-male transsexual patient J Forensic Leg Med 14 6 2007 382 386
22. L. Gooren, M. van Trostsenburg, E. Giltay, and P. van Diest Breast cancer development in transsexual subjects receiving cross-sex hormone treatment J Sex Med 10 12 2013 129 134
23. H.1 Kuroda, K. Ohnisi, G. Sakamoto, and S. Itoyama Clinicopathological study of breast tissue in female-to-male transsexuals Surg Today 38 12 2008 1067 1071
24. N. Miller, Y. Bédard, N. Cooter, and D. Shaul Histological changes in the genital tract in transsexual women following androgen therapy Histopathology 10 7 1986 661 669
25. I. Gardner, J. Safer, S. Mok, R. Weiss, and W. Kuohung "What is the effect of testosterone on the gene expression in the endometrium of transgender men? Oral Presentation at the World Professional Association for Transgender Health (WPATH) Graduate Student Research Symposium held at the 13th Annual Philadelphia Trans Health Conference, Philadelphia, PA June 2014
26. M. Baldassarre, F. Giannone, M. Foschini, C. Battaglia, P. Busacchi, and S. Venturoli Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women Int J Impot Res 25 5 2013 172 177
27. V. Mikhailichenko, V. Fesenko, N. Khmelnitskii, I. Ozhiganova, A. Novikov, and V. Korolev Morphological and functional changes of organs of female and male reproductive systems at change of sex Urologia 3 2013 May-Jun 18 23
28. K. Ikeda, T. Baba, H. Noguchi, K. Nagasawa, T. Endo, and T. Kiya Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology Hum Reprod 28 2 2013 453 461
29. R. Turo, S. Jallad, S. Prescott, and W. Cross Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy Can Urol Assoc J 7 7-8 2013 E544 E546
30. T. Dorff, R. Shazer, E. Nepomuceno, and S. Tucker Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient Clin Genitourin Cancer 5 5 2007 344 346
31. L. Gooren, and A. Morgentaler Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens Andrologia 46 10 2013
32. T. Pritchard, D. Pankowsky, J. Crowe, and F. Abdul-Karim Breast cancer in a male-to-female transsexual. A case report JAMA 259 15 1988 2278 2280
33. T. Pattison, and R. McLaren Triple negative breast cancer in a male-to-female transsexual Intern Med J 43 2 2013 203 205
34. W. Symmers Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics BMJ 2 5597 1968 83 85
35. I. Ganly, and E. Taylor Breast cancer in a trans-sexual man receiving hormone replacement therapy Br J Surg 82 3 1995 341
36. F. Grabellus, K. Worm, A. Willruth, K. Schmitz, F. Otterbach, and H. Baba ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual Breast 14 1 2005 71 74
37. A. Dhand, and G. Dhaliwal Examining patient conceptions: a case of metastatic breast cancer in an African American male to female transgender patient J Gen Intern Med 25 2 2001 158 161
38. T. Shao, M. Grossbard, and P. Lein Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management Clin Breast Cancer 11 6 2011 417 419
39. E. Bowman, G. Oprea, J. Okoli, K. Gundry, M. Rizzo, and S. Gabram-Mendola Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients Breast J 18 3 2012 242 247
40. R. Urban, N. Teng, and D. Kapp Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance Am J Obstet Gynecol 204 5 2011 e9 e12
41. A. Deipolyi, S. Han, and A. Parsa Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of HRT J Clin Neurosci 17 10 2010 1324 1326
42. M. Bergoglio, M. Gómez-Balaguer, E. Almonacid Folch, F. Hurtado Murillo, and A. Hernández-Mijares Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual Endocrinol Nutr 60 5 2013 264 267
43. R. Gazzeri, and M. Galarza Growth of a meningioma in a transsexual patient after Estrogen-Progestin therapy N Engl J Med 357 2007 L2411 L2412
44. K. Kovacs, L. Stefaneanu, S. Ezzat, and H. Smyth Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study Arch Pathol Lab Med 118 5 1994 572 575
45. H. Asscheman, L. Gooren, and P. Eklund Mortality and morbidity in transsexual patients with cross-gender hormone treatment Metabolism 38 9 1989 869 873
46. T. Roberts, C. Kraft, D. French, J. Wuyang, A. Wu, and V. Tangpricha Interpreting laboratory resutls in transgender patients on HRT Am J Med 127 2 2014 159 162
47. J. Jacobeit, L. Gooren, and H. Schulte Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals Eur J Endocrinol 161 5 2009 795 798
48. W. Meyer, A. Webb, C. Stuat, J. Finkelstein, B. Lawrence, and P. Walker Physical and hormonal evaluation of transsexual patients: a longitudinal study Arch Sex Behav 15 2 1986 121 138
49. R. Hampl, L. Stárka, J. Heresova, I. Sípová, Z. Pobisová, and J. Marek The use of andriol in treatment of androgen deficiency in transsexual women J Steroid Biochem 24 1 1986 349 352
50. R. Yahyaoui, I. Esteva, J. Haro-Mora, M. Almaraz, S. Morcillo, and G. Rojo-Martínez Effect of long-term administration of cross-sex HRT on serum and urinary uric acid in transsexual persons J Clin Endocrinol Metab 93 6 2008 2230 2233
51. H. Bosinski, M. Peter, G. Bonatz, R. Arndt, M. Heidenreich, and W. Sippell A higher rate of hyperandrogenic disorders in female-to-male transsexuals Psychoneuroendocrinology 22 5 1997 361 380
52. K. Polderman, L. Gooren, H. Asscheman, A. Bakker, and R. Heine Induction of insulin resistance by androgens and estrogens J Clin Endocrinol Metab 79 1994 265 271
53. E. Resmini, G. Andraghetti, A. Rebora, R. Cordera, L. Vera, and M. Giusti Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments J Androl 29 5 2008 580 585
54. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 8 2001 941 946
55. M. Elbers, H. Asscheman, C. Seidell, and J. Gooren Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals Am J Physiol 6 2 Pt 1 1999 E317 E325
56. G. T'Sjoen, S. Weyers, Y. Taes, B. Lapauw, K. Toye, and S. Goemaere Prevalence of low bone mass in relation to estrogen treatment and body composition in male-to-female transsexual persons J Clin Densitom 12 3 2009 306 313
57. B. Lapauw, Y. Taes, S. Simoens, E. Van Caenegem, S. Weyers, and S. Goemaere Body composition, volumetric and areal bone parameters in male-to-female transsexual persons Bone 43 6 2008 1016 1021
58. A. Mueller, H. Zollver, D. Kronawitter, P.G. Oppelt, T. Claassen, and I. Hoffmann Body composition and bone mineral density in male-to-female transsexuals during cross-sex HRT using gonadotrophin-releasing hormone agonist Exp Clin Endocrinol Diabetes 119 2011 95 100
59. A. Ruestche, R. Kneubuehl, M. Birkhaesuer, and K. Lippuner Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study Osteoporos Int 16 7 2005 791 798
60. H. Asscheman, L.J. Gooren, J. Assies, J.P. Smits, and R. de Slegte Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals Clin Endocrinol (Oxf) 28 6 1988
61. F. Cunha, S. Domenice, V. Camara, M. Sircili, L. Gooren, and B. Mendonca Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy Andrologia 2014 Jul 25 Advance online publication, http://dx.doi.org.10.1111/and.12317
62. L. Gooren, J. Assies, H. Asscheman, R. de Slegte, and H. van Kessel Estrogen-induced prolactinoma in a man J Clin Endocrinol Metab 66 2 1988 444 446
63. M. Bunck, M. Debono, E. Giltay, A. Verheijen, M. Diamant, and L. Gooren Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages BMJ Case Rep 2009 http://dx.doi.org.10.1136/bcr.02.2009.1589
64. K. García-Malpartida, A. Martín-Gorgojo, M. Rocha, M. Gómez-Balaguer, and A. Hernández-Mijares Prolactinoma induced by estrogen and cyproterone acetate in a male-to-female transsexual Fertil Steril 94 3 2010 1097.e13 1097.e15
65. K. Wierckx, E. Elaut, B. Van Hoorde, G. Heylens, G. De Cuypere, and S. Monstrey Sexual desire in trans persons: associations with sex reassignment treatment J Sex Med 11 1 2014 107 118
66. E. Elaut, G. De Cuypere, P. De Sutter, L. Gijs, M. Van Trotsenburg, and G. Heylens Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels Eur J Endocrinol 158 3 2008 393 399
67. D. Kronawitter, L. Gooren, H. Zollver, P. Oppelt, M. Beckmann, and R. Dittrich Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study Eur J Endocrinol 161 2 2009 363 368
68. A. Santos-Ocampo New onset systemic lupus erythematosus in a transgender man: possible role of feminizing sex hormones J Clin Rheumatol 13 1 2007 29 30
69. K. Chan, and C. Mok Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited Lupus 22 13 2013 1399 1402
70. E. Coleman, W. Bockting, M. Botzer, P. Cohen-Kettenis, G. DeCuypere, and J. Feldman Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 Int J Transgenderism 13 4 2012
71. W. Hembree, P. Cohen-Kettenis, H. Delemarre-van de Waal, L. Gooren, W. Meyer, and N. Spack Endocrine treatment of transsexual persons: an endocrine society clinical practice guideline J Clin Endocrinol Metab 94 2009 3132 3154
72. Food and Drug Administration "FDA adding general warning to testosterone products about potential for venous blood clots." Drug Safety and Availability 2014 http://www.fda.gov/Drugs/DrugSafety/ucm401746.htm?source=govdelivery&utm-medium=email&utm-source=govdelivery